Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma.
Saved in:
| Title: | Drug prioritization identifies panobinostat as a tailored treatment element for patients with metastatic hepatoblastoma. |
|---|---|
| Authors: | Demir, Salih1 (AUTHOR), Hotes, Alina1 (AUTHOR), Schmid, Tanja1 (AUTHOR), Cairo, Stefano2,3 (AUTHOR), Indersie, Emilie2 (AUTHOR), Pisano, Claudio4 (AUTHOR), Hiyama, Eiso5 (AUTHOR), Hishiki, Tomoro6 (AUTHOR), Vokuhl, Christian7 (AUTHOR), Branchereau, Sophie8 (AUTHOR), Brock, Penelope9 (AUTHOR), Schmid, Irene10 (AUTHOR), Zsiros, József11 (AUTHOR), Kappler, Roland1 (AUTHOR) roland.kappler@med.uni-muenchen.de |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 11/12/2024, Vol. 43 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
